The state of cell and gene therapy in 2023

遗传增强 疾病 临床试验 计算生物学 基因 生物信息学 生物 基因表达 体内 离体 医学 遗传学 病理
作者
Daniel Chancellor,David Barrett,Ly Nguyen-Jatkoe,Shardha Millington,Fenwick Eckhardt
出处
期刊:Molecular Therapy [Elsevier BV]
卷期号:31 (12): 3376-3388 被引量:30
标识
DOI:10.1016/j.ymthe.2023.11.001
摘要

Progress in the understanding of human diseases has coincided with the advent of precision medicine, whereby the underlying genetic and molecular contributors can be used as diagnostic and therapeutic biomarkers. To address these, drug developers have designed a range of different treatment strategies, including gene therapy, which the American Society of Gene and Cell Therapy defines as the use of genetic material to treat or prevent disease. A number of approaches exist, including the delivery of genetic material in vivo or ex vivo, as well as the use of RNA species to alter gene expression in particular disease states. Through the end of the first quarter of 2023, there were more than 100 different approved gene, cell, and RNA therapies throughout the world, with over 3,700 more in clinical and preclinical development. This review comprehensively captures the landscape for such advanced therapies, including the different genetic technologies used and diseases targeted in clinical trials. Progress in the understanding of human diseases has coincided with the advent of precision medicine, whereby the underlying genetic and molecular contributors can be used as diagnostic and therapeutic biomarkers. To address these, drug developers have designed a range of different treatment strategies, including gene therapy, which the American Society of Gene and Cell Therapy defines as the use of genetic material to treat or prevent disease. A number of approaches exist, including the delivery of genetic material in vivo or ex vivo, as well as the use of RNA species to alter gene expression in particular disease states. Through the end of the first quarter of 2023, there were more than 100 different approved gene, cell, and RNA therapies throughout the world, with over 3,700 more in clinical and preclinical development. This review comprehensively captures the landscape for such advanced therapies, including the different genetic technologies used and diseases targeted in clinical trials.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
张不高发布了新的文献求助10
刚刚
张不高发布了新的文献求助10
刚刚
张不高发布了新的文献求助10
刚刚
1秒前
慕容杏子完成签到,获得积分10
1秒前
2秒前
三叶完成签到,获得积分10
2秒前
石头完成签到,获得积分10
4秒前
悦耳觅夏完成签到 ,获得积分10
4秒前
朴实绾绾发布了新的文献求助10
4秒前
5秒前
xxxxx完成签到,获得积分0
6秒前
GAN完成签到,获得积分10
6秒前
文献looking完成签到,获得积分20
6秒前
kkscanl完成签到 ,获得积分10
7秒前
哦吼完成签到,获得积分10
8秒前
云扬完成签到,获得积分20
8秒前
斯文败类应助夏日香气采纳,获得10
8秒前
研友_VZG7GZ应助三叶采纳,获得10
8秒前
jack1511完成签到,获得积分10
8秒前
清秀的怀蕊完成签到,获得积分10
8秒前
tangyong完成签到,获得积分10
9秒前
tananna完成签到,获得积分10
10秒前
10秒前
傻傻的咖啡豆完成签到,获得积分10
11秒前
哦吼发布了新的文献求助10
11秒前
度帕明发布了新的文献求助10
11秒前
谜呀发布了新的文献求助10
12秒前
李爱国应助陆未离采纳,获得30
12秒前
丘比特应助高兴的万声采纳,获得10
12秒前
yanmh完成签到,获得积分10
13秒前
李小伟完成签到,获得积分10
13秒前
Senna完成签到,获得积分10
14秒前
14秒前
落寞冬云完成签到,获得积分10
14秒前
14秒前
踏月偷心发布了新的文献求助10
15秒前
Prozac完成签到,获得积分10
15秒前
wisdom完成签到,获得积分0
15秒前
16秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Cognitive Neuroscience: The Biology of the Mind 1000
Technical Brochure TB 814: LPIT applications in HV gas insulated switchgear 1000
Immigrant Incorporation in East Asian Democracies 600
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
A Preliminary Study on Correlation Between Independent Components of Facial Thermal Images and Subjective Assessment of Chronic Stress 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3968608
求助须知:如何正确求助?哪些是违规求助? 3513486
关于积分的说明 11168243
捐赠科研通 3248926
什么是DOI,文献DOI怎么找? 1794540
邀请新用户注册赠送积分活动 875188
科研通“疑难数据库(出版商)”最低求助积分说明 804676